quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:09·365d
SECFiling
Enfusion Inc. logo

SEC Form EFFECT filed by Enfusion Inc.

ENFN· Enfusion Inc.
Technology
Original source

Companies

  • ENFN
    Enfusion Inc.
    Technology

Recent analyst ratings

  • May 10UpdateMorgan Stanley$11.00
  • Feb 28UpdateGoldman$8.00
  • Jan 30UpdateJP Morgan$9.00
  • Nov 7UpdateUBS$9.00
  • Apr 3UpdatePiper Sandler$11.00
  • Mar 15UpdateJP Morgan$12.00

Related

  • SEC357d
    SEC Form 15-12G filed by Enfusion Inc.
  • INSIDER365d
    Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)
  • INSIDER365d
    Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)
  • PR366d
    OPENLANE Names Brad Herring Chief Financial Officer
  • INSIDER367d
    Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER367d
    Chief Financial Officer Herring Bradley returned 324,689 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER367d
    Chief Executive Officer Movchan Oleg returned 1,783,665 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER367d
    Director Leibowitz Lawrence E returned 175,572 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022